Study finds beta blockers reduce risk of death after surgery

Sep 29, 2010 By Steve Tokar

Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.

“We are reducing the short- and long-term risk of death after surgery by about 35 percent with beta blockers,” says lead author Arthur W. Wallace, MD, PhD, an at SFVAMC and a professor of anesthesiology at the University of California, San Francisco. “And we are doing it for a total cost of about one dollar per patient.”

Beta blockers lower heart rate by blocking the effects of , which in turn reduces the risk of chest pain or myocardial ischemia (reduced blood supply to the heart) that can occur when a rapidly beating heart does not receive adequate blood flow.

The study appears in the October 2010 issue of the journal Anesthesiology.

The analysis of 38,779 surgeries of all types performed at SFVAMC from 1996 to 2008 is the largest in a clinical setting of the protocol known as perioperative beta blockade, which calls for beta blockers to be given to surgical patients with , vascular disease, or at least two risk factors for coronary artery disease.

The study showed that surgical patients who were already taking beta blockers before surgery and had at least one dose after surgery, as well as patients not on beta blockers who were given at least one dose after , had a significantly lower 30-day and one-year post-operative mortality rate than patients who never received .

Wallace and his colleagues developed and implemented perioperative beta blockade at SFVAMC in 1998 and have helped introduce its use into general surgical practice in the United States.

“This shows what the VA medical system can do,” says Wallace. “We researched and developed a therapy that reduces perioperative mortality by 35 percent, implemented it, spread the idea to other hospitals, and thanks to the VA’s automated medical records system, we are able to demonstrate that it works safely in a very large sample of patients.”

Explore further: Nutritional supplement boosts muscle stamina in animal studies

Related Stories

Studies unclear on role of pre-surgery beta blockers

Feb 09, 2010

In a commentary appearing in this week's Journal of the American Medical Association, heart specialists at the University of Michigan Health System make a plea for clarity on the best approach for prescribing beta blocke ...

Beta-blockers given the boot in Britain

Jun 28, 2006

British doctors are being advised not to prescribe beta-blockers and to ease most current users off them and onto new treatment for high blood pressure.

Recommended for you

Organ transplant rejection may not be permanent

6 hours ago

Rejection of transplanted organs in hosts that were previously tolerant may not be permanent, report scientists from the University of Chicago. Using a mouse model of cardiac transplantation, they found that immune tolerance ...

Researchers find key mechanism that causes neuropathic pain

8 hours ago

Scientists at the University of California, Davis, have identified a key mechanism in neuropathic pain. The discovery could eventually benefit millions of patients with chronic pain from trauma, diabetes, shingles, multiple ...

Deep sea light shines on drug delivery potential

8 hours ago

A naturally occurring bioluminescent protein found in deep sea shrimp—which helps the crustacean spit a glowing cloud at predators—has been touted as a game-changer in terms of monitoring the way drugs ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.